Methods Study Design CARTITUDE-1 (ClinicalTrials.gov identifier: NCT03548207) was a phase Ib/II, open-label, multicenter study of cilta-cel in patients with RRMM. The study design was previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback